Indian Stock Market Summary: Nifty50 and BSE Sensex Rise on February 18, 2026

The Indian stock market showed positive momentum on February 18, 2026, as equity indices extended their winning streak into a third day. The Nifty 50 index increased by 0.37% to finish at 25,819.35, while the BSE Sensex rose by 0.34% to settle at 83,734.25. This marks a notable recovery after both benchmarks opened lower and faced a lacklustre start.

Several factors contributed to the rally, primarily driven by gains in the financial and metal sectors. Financial stocks, particularly state-owned banks, added approximately 1.3%, following a 2.1% rise in the previous trading session. The heaviest-weighted financial sector saw a rise of 0.6%, while metal stocks surged by 1.3% after reports suggested that the U.S. is considering easing steel tariffs amidst industry concerns.

Prominent gainers within the metal sector included Tata Steel, which rose by 2.9%, JSW Steel, up by 0.7%, and Steel Authority of India, gaining 1.4%. In contrast, the information technology index lagged, declining by 1.2%, with every constituent falling. Infosys witnessed a drop of 1.3%, reversing gains from the previous session.

In the broader market, small-cap and mid-cap stocks mirrored the trends seen in larger indices, both appreciating by 0.5%. Overall, fifteen out of sixteen major sector indices recorded positive gains.

The Indian rupee also experienced a slight appreciation, climbing by 6 paise to close at 90.66 against the US dollar, buoyed by an influx of foreign investments and the upbeat performance of domestic equity markets, contributing to the overall bullish sentiment.

The day's trading statistics revealed that out of approximately 4,328 stocks exchanged on the Bombay Stock Exchange, 2,224 advanced while 1,903 declined, with some stocks reaching notable highs and lows. A total of 105 stocks achieved their 52-week highs, while 91 fell to their 52-week lows.

Among significant corporate news, State Bank of India Funds Management announced plans for a $1.5 billion Initial Public Offering set for March, despite the current downturn in the Indian public offering market. Additionally, Kotak Alternate Asset Managers Limited, through its Kotak Life Sciences Fund I, invested INR 400 million in Zeroharm Sciences to propel growth and expand its market presence.

Investors remain cautious heading into future sessions, with ongoing geopolitical developments influencing market dynamics. The minutes from the Federal Reserve’s January meeting are awaited, as they may provide further clarity on the trajectory of interest rates, which could impact various asset prices across the board.

Market analysts suggest that the prevailing market strategy should lean towards a buy-on-dips and sell-on-rallies approach, especially with precious metals like gold and silver experiencing price consolidations amidst fluctuating dollar strength.

As the market continues to navigate through volatility and geopolitical uncertainties, investors are advised to stay informed and exercise strategic caution in their investment decisions.